On July 7, Robert H.S. Goe, Vice Chairman of GoeGoe Honglin Pharmaceutical—a vice president unit of the China Association of Small and Medium Enterprises—along with Zhang Qi, General Manager of GoeGoe Honglin Biopharmaceutical (Jiangsu) Co., Ltd., visited the Shanghai Representative Office of the China Association of Small and Medium Enterprises. They held in-depth discussions with Yi Yuqian, Founding Director of the office, on deepening member services and strategic cooperation. Xu Jingjing, Office Director of the Shanghai Representative Office, also attended the meeting.

During the talks, Vice Chairman Robert H.S. Goe introduced the core business of GoeGoe Honglin Pharmaceutical in the biopharmaceutical sector, outlined the company’s development plans for the second half of the year, and expressed hope that the Shanghai Representative Office would provide support in areas such as policy interpretation and resource linkage. This support is expected to help the company seize policy opportunities and achieve efficient growth.

Director Yi Yuqian fully affirmed the innovative practices of GoeGoe Honglin Pharmaceutical and elaborated on the service platform functions of the Shanghai Representative Office. He emphasized that the office remains committed to serving small and medium-sized enterprises by offering comprehensive support through policy consultation, technical collaboration, and industrial chain connectivity. Moving forward, both parties will deepen cooperation in promoting the upgrade of the biopharmaceutical industry in the Yangtze River Delta, jointly fostering regional economic vitality.

This meeting laid a solid foundation for collaboration between the two sides. The Shanghai Representative Office of the China Association of Small and Medium Enterprises will continue to serve as a bridge, working hand in hand with enterprises to promote high-quality development.